I-Mab
Anti-PD-L1 antibody and IL-7 fusions

Abstract:

Provided are fusion molecule having a PD-L1 inhibitor fused to a human IL-7 protein or fragment thereof through a peptide linker. The disclosed fusion molecules exhibited synergistic anti-tumor effects.